133 related articles for article (PubMed ID: 14642532)
21. Syndecan family of cell surface proteoglycans: developmentally regulated receptors for extracellular effector molecules.
Salmivirta M; Jalkanen M
Experientia; 1995 Sep; 51(9-10):863-72. PubMed ID: 7556568
[TBL] [Abstract][Full Text] [Related]
22. Expression of syndecan-2, -4, and fibroblast growth factor receptor type 1 in human periodontal ligament fibroblasts and down-regulation of these membrane proteins during maturation in culture.
Shimazu A; Bachchu MA; Morishita M; Noshiro M; Kato Y; Iwamoto Y
J Dent Res; 1999 Dec; 78(12):1791-9. PubMed ID: 10598908
[TBL] [Abstract][Full Text] [Related]
23. Antisense inhibition of syndecan-3 expression during skeletal muscle differentiation accelerates myogenesis through a basic fibroblast growth factor-dependent mechanism.
Fuentealba L; Carey DJ; Brandan E
J Biol Chem; 1999 Dec; 274(53):37876-84. PubMed ID: 10608853
[TBL] [Abstract][Full Text] [Related]
24. Soluble syndecan-1 promotes growth of myeloma tumors in vivo.
Yang Y; Yaccoby S; Liu W; Langford JK; Pumphrey CY; Theus A; Epstein J; Sanderson RD
Blood; 2002 Jul; 100(2):610-7. PubMed ID: 12091355
[TBL] [Abstract][Full Text] [Related]
25. Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors.
Bernfield M; Sanderson RD
Philos Trans R Soc Lond B Biol Sci; 1990 Mar; 327(1239):171-86. PubMed ID: 1969657
[TBL] [Abstract][Full Text] [Related]
26. Expression of syndecan-1 inhibits cell invasion into type I collagen.
Liebersbach BF; Sanderson RD
J Biol Chem; 1994 Aug; 269(31):20013-9. PubMed ID: 8051085
[TBL] [Abstract][Full Text] [Related]
27. Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells.
Park H; Kim Y; Lim Y; Han I; Oh ES
J Biol Chem; 2002 Aug; 277(33):29730-6. PubMed ID: 12055189
[TBL] [Abstract][Full Text] [Related]
28. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds.
Gallo RL; Ono M; Povsic T; Page C; Eriksson E; Klagsbrun M; Bernfield M
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11035-9. PubMed ID: 7972004
[TBL] [Abstract][Full Text] [Related]
29. Syndecan-2 expression increases serum-withdrawal-induced apoptosis, mediated by re-distribution of Fas into lipid rafts, in stably transfected Swiss 3T3 cells.
Villena J; Mainez J; Noguer O; Contreras H; Granés F; Reina M; Fabregat I; Vilaró S
Apoptosis; 2006 Nov; 11(11):2065-75. PubMed ID: 17041758
[TBL] [Abstract][Full Text] [Related]
30. Control of morphology, cytoskeleton and migration by syndecan-4.
Longley RL; Woods A; Fleetwood A; Cowling GJ; Gallagher JT; Couchman JR
J Cell Sci; 1999 Oct; 112 ( Pt 20)():3421-31. PubMed ID: 10504291
[TBL] [Abstract][Full Text] [Related]
31. Syndecan-2 overexpression induces osteosarcoma cell apoptosis: Implication of syndecan-2 cytoplasmic domain and JNK signaling.
Modrowski D; Orosco A; Thévenard J; Fromigué O; Marie PJ
Bone; 2005 Aug; 37(2):180-9. PubMed ID: 15936998
[TBL] [Abstract][Full Text] [Related]
32. Syndecan-3 and the control of chondrocyte proliferation during endochondral ossification.
Shimazu A; Nah HD; Kirsch T; Koyama E; Leatherman JL; Golden EB; Kosher RA; Pacifici M
Exp Cell Res; 1996 Nov; 229(1):126-36. PubMed ID: 8940256
[TBL] [Abstract][Full Text] [Related]
33. Syndecan-1 in B lymphoid malignancies.
Sanderson RD; Børset M
Ann Hematol; 2002 Mar; 81(3):125-35. PubMed ID: 11904737
[TBL] [Abstract][Full Text] [Related]
34. Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development.
Ford-Perriss M; Turner K; Guimond S; Apedaile A; Haubeck HD; Turnbull J; Murphy M
Dev Dyn; 2003 Jun; 227(2):170-84. PubMed ID: 12761845
[TBL] [Abstract][Full Text] [Related]
35. Increased syndecan expression by pleiotrophin and FGF receptor-expressing astrocytes in injured brain tissue.
Iseki K; Hagino S; Mori T; Zhang Y; Yokoya S; Takaki H; Tase C; Murakawa M; Wanaka A
Glia; 2002 Jul; 39(1):1-9. PubMed ID: 12112370
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ
J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
[TBL] [Abstract][Full Text] [Related]
37. Syndecan-1 regulates FGF8b responses in S115 mammary carcinoma cells.
Viklund L; Vorontsova N; Henttinen T; Salmivirta M
Growth Factors; 2006 Jun; 24(2):151-7. PubMed ID: 16801134
[TBL] [Abstract][Full Text] [Related]
38. Syndecan-2 induces filopodia by active cdc42Hs.
Granés F; García R; Casaroli-Marano RP; Castel S; Rocamora N; Reina M; Ureña JM; Vilaró S
Exp Cell Res; 1999 May; 248(2):439-56. PubMed ID: 10222136
[TBL] [Abstract][Full Text] [Related]
39. The role of syndecan-1 in malignancies.
Inki P; Jalkanen M
Ann Med; 1996 Feb; 28(1):63-7. PubMed ID: 8932508
[TBL] [Abstract][Full Text] [Related]
40. Specific structural features of syndecans and heparan sulfate chains are needed for cell signaling.
Lopes CC; Dietrich CP; Nader HB
Braz J Med Biol Res; 2006 Feb; 39(2):157-67. PubMed ID: 16470302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
